Dicyclomine, benzhexol and oxybutynine distinguish between subclasses of muscarinic binding sites

European Journal of Pharmacology
L Nilvebrant, B Sparf

Abstract

The interactions of various unlabelled antimuscarinic drugs with the muscarinic receptors in the cerebral cortex, heart and urinary bladder were studied by a receptor binding technique, using (-)[3H]QNB as radioligand. In contrast to the other drugs examined, dicyclomine, benzhexol, oxybutynine and pirenzepine were bound with a significantly higher affinity in the cortex than in the heart and bladder. Furthermore, not only pirenzepine, but also dicyclomine and benzhexol were capable of distinguishing between two populations of muscarinic binding sites in the cortex. The low affinity sites for these drugs in the cortex were characterised by dissociation constants which were similar to those determined in the heart and the bladder, respectively. It was concluded that dicyclomine and benzhexol, like pirenzepine, are selective antagonists at the putative M1-receptor. Oxybutynine exhibited the same affinity profile but the tissue selectivity of this drug was less pronounced.

References

Feb 1, 1977·Archives of General Psychiatry·S H Snyder, H I Yamamura
Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·H SugiyamaM Nirenberg
May 1, 1975·Acta Physiologica Scandinavica·L Terenius, A Wahlström
Aug 1, 1985·The Journal of Urology·L NilvebrantA Mattiasson
Feb 13, 1980·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·N J BirdsallA Burgen
Jan 1, 1984·Nihon rinsho. Japanese journal of clinical medicine·S KishimotoA Miyoshi
Feb 29, 1984·Biochemical and Biophysical Research Communications·K AkiyamaH I Yamamura
Jan 1, 1983·Hearing Research·W M JamesW L Klein
Jan 1, 1983·Acta Pharmacologica Et Toxicologica·L Nilvebrant, B Sparf
Dec 1, 1982·British Journal of Pharmacology·I Szelenyi
Jul 17, 1981·European Journal of Pharmacology·E C HulmeA S Burgen
Jan 1, 1980·British Journal of Pharmacology·W J TaylorJ M Young

❮ Previous
Next ❯

Citations

Jan 1, 1992·Journal of Neural Transmission. General Section·A Nordberg, G Wahlström
Sep 15, 2012·International Urogynecology Journal·Kelly Jirschele, Peter K Sand
Sep 13, 1988·European Journal of Pharmacology·L Noronha-BlobW J Kinnier
Oct 26, 1988·European Journal of Pharmacology·S B FreedmanE A Harley
Jun 22, 1988·European Journal of Pharmacology·L Nilvebrant, B Sparf
Oct 16, 1995·European Journal of Pharmacology·N WatsonR M Eglen
Jan 1, 1988·Pharmacology & Therapeutics·F Mitchelson
May 30, 1997·European Journal of Pharmacology·L NilvebrantB Sparf
Apr 29, 1999·Neuropharmacology·C GhelardiniA Bartolini
Jan 1, 1992·British Journal of Pharmacology·A BartoliniA Giotti
Mar 1, 1995·British Journal of Pharmacology·M H Richards, P L van Giersbergen
Jan 1, 1991·Pharmacology & Toxicology·L Nilvebrant, C Nordin
Jul 11, 2007·Postgraduate Medical Journal·Sushma SrikrishnaMaria Vella
Jun 14, 2001·Journal of Clinical Pharmacology·A TodorovaW Dimpfel
Sep 11, 2003·Drugs & Aging·A Wagg
Mar 1, 2006·Women's Health·Dudley Robinson, Linda Cardozo
Mar 2, 2010·Women's Health·Monika VijLinda Cardozo
Jan 23, 2016·Expert Opinion on Pharmacotherapy·Helena Burden, Paul Abrams
Aug 1, 1988·British Journal of Pharmacology·H Kilbinger, A Stein
Dec 1, 1987·British Journal of Pharmacology·A D Michel, R L Whiting
Jan 1, 2008·Expert Review of Clinical Pharmacology·Dudley Robinson, Linda Cardozo
Jul 23, 2019·Clinical and Experimental Pharmacology & Physiology·Hongliang LiWon Sun Park
Sep 1, 1988·The Journal of International Medical Research·R Ruffmann
Nov 26, 1999·BJU International·K E AnderssonR Vela Navarrete
Sep 11, 2003·Drugs & Aging·Lynne M BangCaroline M Perry
Sep 1, 1987·The Journal of Urology·S B MalkowiczR M Levin
Feb 1, 1987·The Journal of Pharmacy and Pharmacology·M ToniniA Crema
Oct 1, 1986·Acta Pharmacologica Et Toxicologica·L NilvebrantL Malmberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.